In the news release, Neurocrine Biosciences to Present at the
Morgan Stanley Global Healthcare Conference, issued 10-Sep-2015 by Neurocrine Biosciences, Inc. over
PR Newswire, the first paragraph, first sentence, should read
"President" rather than "resident" as incorrectly transmitted by PR
Newswire. The complete, corrected release follows:
Neurocrine Biosciences to Present at the Morgan Stanley Global
Healthcare Conference Live Audio Webcast Will be on
September 17, 2015
SAN DIEGO, Sept. 10, 2015 /PRNewswire/ -- Neurocrine
Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and CEO of Neurocrine
Biosciences, will be presenting at the Morgan Stanley Global
Healthcare Conference in New York
City.
The live presentation takes place on Thursday, September 17 at 8:00am ET (5:00am
PT). The presentation will be webcast and may be
accessed on the Company's website at
http://www.neurocrine.com.
Listeners are encouraged to visit the website approximately 5
minutes prior to the presentation to download or install any
necessary software. A replay of the presentation will be
available on the website approximately one hour after the
conclusion of the event and will be archived for one month.
About Neurocrine Biosciences
Neurocrine Biosciences, Inc. discovers and develops innovative
and life-changing pharmaceuticals, in diseases with high unmet
medical needs, through its novel R&D platform, focused on
neurological and endocrine based diseases and disorders. The
Company's two lead late-stage clinical programs are elagolix, a
gonadotropin-releasing hormone antagonist for women's health that
is partnered with AbbVie Inc., and NBI-98854, a vesicular monoamine
transporter 2 inhibitor for the treatment of movement
disorders. Neurocrine intends to maintain certain commercial
rights to its VMAT2 inhibitor for evolution into a fully-integrated
pharmaceutical company.
Neurocrine Biosciences, Inc. news releases are available through
the Company's website via the internet at
http://www.neurocrine.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-the-morgan-stanley-global-healthcare-conference-300140271.html
SOURCE Neurocrine Biosciences, Inc.